Dr. Noor Abbott

Oncology pharmacist · Hospital Clínic Barcelona · Spain (ES) · Oncology

Tier 2STK-0041GoodOwner MSL RARachel Adeyemi

Data minimisation

Consent status: Recorded. The name shown may be a pseudonym. Contact details, personal identifiers and remuneration fields are hidden for your role; only scientific-profile fields needed for engagement planning are displayed.

Specialty: Thoracic oncology
Disease interests: NSCLC, SCLC
Scientific interests: PD-L1 biomarkers
Engagement preference: In person
Advisory boards: 1
Publications: 35
Source system: Veeva CRM
Data quality: Good

Engagement plan

Cadence target for Tier 2: 2 per year (assumption)

Last engaged: 23 Jul 2026 (54 days ago)
Next planned contact: 22 Jan 2027
Last 6 months vs target: 100%
2 of 1 expected engagements

Insights from this stakeholder (1)

INS-0053Brain-metastasis subgroup data
08 Jan 2026 · Efficacy
HighArchived

Engagement history (3)

All engagements including drafts, newest first

Date	Type	Format	MSL	Product	Topics	Insights	Flags	Status
23 Jul 2026	Payer / HTA meeting	Phone	Rachel Adeyemi	Vantrexa	Comparator checkpoint monotherapy	0	—	Reviewed	ENG-0023
08 May 2026	Scientific exchange	In person	Rachel Adeyemi	Vantrexa	Infusion-reaction management	0	Safety	Reviewed	ENG-0039
07 Jan 2026	Scientific exchange	Phone	Rachel Adeyemi	Vantrexa	Brain-metastasis subgroup data	1	—	Reviewed	ENG-0054

Timeline

23 Jul 2026
Payer / HTA meeting
Comparator checkpoint monotherapy
08 May 2026
Scientific exchange
Infusion-reaction management
07 Jan 2026
Scientific exchange
Brain-metastasis subgroup data

Related stakeholders (7)

Hospital Clínic Barcelona

Dr. Valentina Hayashi
Oncology pharmacist
Tier 2
Dr. Rosa Bauer
Radiation oncologist
Tier 1
Dr. Hiroshi Xu
Radiation oncologist
Tier 2
Dr. Benedikt Rossi
Primary care physician
Tier 3
Dr. Quentin Abbott
General neurologist
Tier 2
Dr. Chloé Ivanova
Headache specialist
Tier 1
Dr. Ingrid Bauer
General neurologist
Tier 1